An Overview of Healthcare Investment Risks

​Healthcare investing offers lucrative opportunities for investors in the long term, driven by technology, the growing demand for medical services, and an aging population. However, investing in the healthcare sector also comes with risks, such as regulatory changes.

Every aspect of the healthcare sector presents its unique investment challenges, including biotech startups, pharmaceutical companies, exchange-traded funds (ETFs), and healthcare providers. Investors should understand and prepare to manage risks in a bid to preserve their capital.

 The healthcare sector remains one of the most regulated sectors. Drugs undergo a series of approvals and testing. Healthcare operations must comply with various health standards and policies, which are subject to change. These policy changes can have either a positive or negative impact on healthcare investments. For instance, the ban on specific drugs might result in pharmaceutical companies running at a loss. Similarly, denied or delayed US Food and Drug Administration (FDA) approval for certain medical products might destroy a biotech’s stock.

Market volatility also affects healthcare investment. Investments in biotechnology and pharmaceutical stocks seem particularly more subject to market volatility. This can be a result of the industry's nature. For instance, a biotech’s stocks might rise or fall solely because of the success or failure of a drug or procedure. Also, the outcomes of clinical trials may determine whether investors will invest their capital. Safety concerns and product recalls can erode public confidence in a health product, negatively impacting investment.

Next, innovation, research, and development risk often affect healthcare investments. Research and development are very expensive. Without research and development, it is almost impossible to conduct a clinical trial or develop a successful treatment. However, a failed treatment or clinical trial might result in a loss worth millions of dollars. Startups are particularly susceptible to these types of risks.

Operational and execution risk occurs when healthcare companies struggle with supply chain issues, managerial inefficiencies, and labor shortages. Supply chain disruptions can adversely affect the production and delivery of medical products. Managerial inefficiencies, such as compliance failures and poor strategic decision-making, can cost a healthcare company millions of dollars in investments. Also, labour shortages for roles such as laboratory technicians, pharmacists, and nurses can put pressure on the supply of goods and services.

Diversification helps mitigate health investment risks. The healthcare sector encompasses a range of sub-sectors, including pharmaceuticals, biotechnology, medical devices, and healthcare services. By spreading your investments across these different areas, you reduce your exposure to risks that may affect one specific segment. For example, exchange-traded funds (ETFs) like the Vanguard Health Care ETF (VHT) or the Health Care Select Sector SPDR Fund (XLV) have built-in diversification, making it easier for investors to access a broad mix of healthcare companies.

Investors can focus on established, large-cap companies with strong track records. Well-known names like Johnson & Johnson and Pfizer have consistently proven their ability to generate profits, even through industry changes and economic uncertainty. These companies are generally more resilient in the face of challenges, such as regulatory changes or setbacks from a single product. Investing in businesses with a long history of stability and innovation offers a more secure foundation for long-term growth.

Additionally, staying informed about regulatory trends, FDA decisions, and global healthcare policies can help you anticipate changes in the market. Following reputable news sources, analyst updates, and official government announcements can provide the insight needed to make informed and timely investment decisions.

Paul Generale

Shop